S-309309

Shionogi · Phase 2 active Small molecule

At a glance

Generic name	S-309309
Sponsor	Shionogi
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy Study of S-309309 in Obese Adults (PHASE2)
Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants (PHASE1)
A Study to Assess S-309309 in Healthy and Obese Participants (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

S-309309 CI brief — competitive landscape report
S-309309 updates RSS · CI watch RSS
Shionogi portfolio CI